MarketCap
Facebook
X
Telegram
Country |
 USA |
IPO year |
2000 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
155 M |
Market Cap[1] |
$ 30.1 B |
EBITDA (LTM) |
$ 1.07 B |
P/E (LTM) |
38.99 |
P/S (LTM) |
6.06 |
EPS (LTM) |
4.18 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Medpace Holdings
MEDP
|
$ 601.38 | -0.73 % | $ 17.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Celcuity
CELC
|
$ 82.62 | -6.47 % | $ 3.86 B | Nasdaq Global Select Market | USA |
 |
Mettler-Toledo International
MTD
|
$ 1 327.18 | -0.15 % | $ 27.4 B | NYSE,SPB |  Schweiz |
 |
Myriad Genetics
MYGN
|
$ 5.61 | -1.58 % | $ 519 M | Nasdaq Global Select Market,SPB | USA |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
NeoGenomics
NEO
|
$ 13.89 | -2.46 % | $ 1.78 B | Nasdaq Global Select Market,SPB | USA |
 |
Neogen Corporation
NEOG
|
$ 9.4 | -2.19 % | $ 2.04 B | Nasdaq Global Select Market,SPB | USA |
 |
Natera
NTRA
|
$ 261.99 | -1.02 % | $ 35.8 B | Nasdaq Global Select Market,SPB | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
OPKO Health
OPK
|
$ 1.22 | 4.27 % | $ 847 M | Nasdaq Global Select Market | USA |
 |
Pacific Biosciences of California
PACB
|
$ 1.36 | -2.86 % | $ 408 M | Nasdaq Global Select Market,SPB | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
Co-Diagnostics
CODX
|
$ 2.1 | -4.98 % | $ 2.79 M | Nasdaq Capital Market | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market |  Israel |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Quidel Corporation
QDEL
|
$ 16.05 | -3.2 % | $ 676 M | Nasdaq Global Select Market,SPB | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE |  China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
Neuronetics
STIM
|
$ 1.73 | -7.98 % | $ 114 M | Nasdaq Global Select Market | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
Trinity Biotech plc
TRIB
|
$ 8.45 | -5.73 % | $ 3.04 B | Nasdaq Global Select Market |  Irlanda |
 |
Twist Bioscience Corporation
TWST
|
$ 90.27 | -2.35 % | $ 5.4 B | Nasdaq Global Select Market,SPB | USA |
 |
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | USA |
 |
CareDx, Inc
CDNA
|
$ 37.14 | -1.25 % | $ 1.98 B | Nasdaq Global Market,SPB | USA |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE |  Niderland |
 |
Soleno Therapeutics
SLNO
|
- | - | $ 2.69 B | Nasdaq Capital Market | USA |
 |
DarioHealth Corp.
DRIO
|
$ 7.79 | 4.28 % | $ 31 M | Nasdaq Capital Market | Israel |
 |
Quest Diagnostics Incorporated
DGX
|
$ 227.86 | -0.02 % | $ 25.3 B | NYSE,SPB | USA |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
Biomerica
BMRA
|
$ 1.59 | -0.94 % | $ 3.65 M | Nasdaq Capital Market | USA |
 |
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | USA |
 |
Organovo Holdings
ONVO
|
- | -2.3 % | $ 19.4 M | Nasdaq Capital Market | USA |
 |
OpGen
OPGN
|
- | -16.95 % | $ 1.54 M | Nasdaq Capital Market | USA |
 |
Anixa Biosciences
ANIX
|
$ 3.7 | -1.33 % | $ 120 K | Nasdaq Capital Market | USA |
 |
PerkinElmer
PKI
|
- | -0.91 % | $ 14.7 B | NYSE,SPB | USA |
 |
DexCom
DXCM
|
$ 71.54 | 1.5 % | $ 27.9 B | Nasdaq Global Select Market,SPB | USA |
 |
Psychemedics Corporation
PMD
|
- | -1.84 % | $ 15.3 M | Nasdaq Global Select Market | USA |
 |
ICON Public Limited Company
ICLR
|
$ 165.76 | -2.68 % | $ 13 B | Nasdaq Global Select Market,SPB | Irlanda |
 |
Quotient Limited
QTNT
|
- | -11.32 % | $ 1.1 M | Nasdaq Global Select Market | Schweiz |
 |
T2 Biosystems
TTOO
|
- | -39.35 % | $ 313 K | Nasdaq Global Select Market | USA |
 |
Renalytix AI plc
RNLX
|
- | 5.66 % | $ 22.7 M | Nasdaq Global Market | Britain |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.